News

Hosted on MSN1mon
Scientists analyze multiple genetic variants of familial chilomicronemia syndrome, an ultrarare disease
More information: Mj Ariza et al, Pathogenicity assessment of genetic variants identified in patients with severe hypertriglyceridemia: novel cases of Familial Chylomicronemia Syndrome from the ...
Baylor College of Medicine13d
Transforming the recognition and management of persistent chylomicronemia
A new framework for the categorization and management of chylomicronemia - an extreme form of hypertriglyceridemia defined as triglyceride (TG) ...
Rona Therapeutics Receives IND Clearance from FDA to Initiate Phase 2 Study of RN0361: an APOC3 Targeted siRNA for Management of Hypertriglyceridemia
Rona Therapeutics Inc., a global leader in RNA-targeted therapeutics, announced the clearance of an Investigational New Drug (IND) by the U.S. Food and Drug Administration (FDA) for RN0361-an APOC3 ...
The Victoria Advocate25d
Rona Therapeutics Receives IND Clearance from FDA to Initiate Phase 2 Study of RN0361: an APOC3 Targeted siRNA for Management of Hypertriglyceridemia
therapeutic for severe hypertriglyceridemia (SHTG), mixed dyslipidemia, and familial chylomicronemia syndrome (FCS) treatment. The company plans to advance RN0361 development in HTG patients based ...